drugset / Trial / NCT02349607
Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints
RandomizedCrossoverDouble-blindBasic science
Summary
This study will examine the activity of PF-05089771 and pregabalin, alone and in combination on a panel of evoked pain tests carried out from 0.5 to 10 hours following oral dosing in healthy male subjects
Timeline
- Start
- 2015-01
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ibuprofen | Small molecule | 600 mg | — |
| Subject | PF-05089771 | Small molecule | 300 mg | Oral |
| Subject | Pregabalin | Small molecule | 300 mg | Oral |
Indications
No indication recorded.